KD Logo

REGN’s latest rating updates from top analysts.

Regeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $1.19 million on Jul 01 ’24. In the deal valued at $1047.11 per share,1,137 shares were sold. As a result of this transaction, McCourt Marion now holds 12,931 shares worth roughly $13.63 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, RYAN ARTHUR F sold 100 shares, generating $105,924 in total proceeds. Upon selling the shares at $1059.24, the Director now owns 17,882 shares.

Before that, Bassler Bonnie L sold 756 shares. Regeneron Pharmaceuticals, Inc. shares valued at $802,872 were divested by the Director at a price of $1062.00 per share. As a result of the transaction, Bassler Bonnie L now holds 1,382 shares, worth roughly $1.46 million.

Bernstein initiated its Regeneron Pharmaceuticals, Inc. [REGN] rating to an Outperform in a research note published on March 12, 2024; the price target was $1125. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid January from “a Sector perform” to “an Outperform”. Deutsche Bank began covering REGN with “Hold” recommendation on November 09, 2023. Raymond James revised its rating on November 03, 2023. It rated REGN as “an Outperform” which previously was an “a Mkt perform”.

Price Performance Review of REGN

On Tuesday, Regeneron Pharmaceuticals, Inc. [NASDAQ:REGN] saw its stock jump 0.17% to $1054.03. Over the last five days, the stock has lost -0.28%. Regeneron Pharmaceuticals, Inc. shares have risen nearly 20.01% since the year began. Nevertheless, the stocks have risen 52.22% over the past one year. While a 52-week high of $1081.17 was reached on 06/25/24, a 52-week low of $688.52 was recorded on 01/02/24. SMA at 50 days reached $997.02, while 200 days put it at $915.14. A total of 0.27 million shares were traded, compared to the trading of 0.37 million shares in the previous session.

Levels Of Support And Resistance For REGN Stock

The 24-hour chart illustrates a support level at 1,043.02, which if violated will result in even more drops to 1,032.02. On the upside, there is a resistance level at 1,062.02. A further resistance level may holdings at 1,070.02. The Relative Strength Index (RSI) on the 14-day chart is 60.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.05%. Stochastics%K at 50.60% indicates the stock is a holding.

Most Popular